
Financial Times
Jan 17, 2023 - 5 min
Following decades of failures in Alzheimer's research, Eli Lilly & Co. could be on the cusp of a breakthrough. Lisa Jarvis reports on a new drug that could slow the onset of the disease.
For more articles like this please visit us at www.bloomberg.com